Yield10 Bioscience, Inc. (YTEN)

1 member of Congress has disclosed 4 trades in Yield10 Bioscience, Inc. (YTEN) via STOCK Act filings. The most recent disclosure was a sale by Roger Marshall on 14 March 2018. Aggregate disclosed activity totals roughly $32K in sales (midpoint estimates from bracketed disclosure amounts).

Want to automatically copy Pelosi trades?

Mirror Nancy Pelosi's portfolio with just one click on eToro.

Claim Free AssetCopy Automatically with eToro

Copy Trading does not amount to investment advice. The value of your investments may go up or down. Your capital is at risk.

Past Performance is not an indication of future results.

Price data is not available for YTEN
This ticker may have been delisted, renamed, or is not publicly quoted, so no live price, statistics or chart can be shown. The congressional trades disclosed for it are listed below.

Congressional Trading Activity for YTEN

4 transactions
Compliance: 0%
Roger Marshall14 Mar 201813 Aug 2019SaleStock$1,001 - $15,000N/A
Roger Marshall14 Mar 201824 Sept 2021SaleStock$1,001 - $15,000N/A
Roger Marshall14 Mar 201813 Aug 2020SaleStock$1,001 - $15,000N/A
Roger Marshall14 Mar 20186 Aug 2018SaleStock$1,001 - $15,000N/A

Stock Overview

Market Data

Market Cap

$345.46K

Volume

11.43K

Beta

1.43

P/E Ratio

-0.02

Fundamentals

EPS

$-20.14

Div. Yield

-

Open

$0.69

Day Range

$0.34 – $0.69

Company Information

Sector
Basic Materials
Industry
Agricultural Inputs
Exchange
NASDAQ · USD
Country
US
CEO
Oliver P. Peoples
IPO Date
2006-11-10
Website
www.yield10bio.com

Yield10 Bioscience, Inc. is an agricultural biotechnology firm dedicated to creating advanced solutions that can significantly boost crop productivity across the United States and Canada. Utilizing its proprietary Trait Factory – an innovative gene d...

Earnings

Recent Quarters

Q2 202512 Aug
EPS-
Q1 202513 May
EPS-
Q3 202418 Nov
EPS-
Q2 202414 Aug
EPS$-5.04
Miss 27.3%
Q1 20241 Apr
EPS$-6.47
Miss 145.1%
Q4 202312 Mar
EPS$-0.27
Beat 10.0%
Q3 202314 Nov
EPS$-9.83
Miss 32.3%
Q2 202314 Aug
EPS$-15.35
Miss 33.4%
Q1 202310 May
EPS$-18.23
Miss 69.0%
Q4 202214 Mar
EPS$-16.07
Miss 2778.3%
Q3 202214 Nov
EPS$-17.03
Miss 1.4%
Q2 202210 Aug
EPS$-16.79
Miss 1.4%
Q1 202211 May
EPS$-16.31
Miss 3.0%
Q4 20219 Mar
EPS$-14.63
Miss 2203.9%
Q3 202110 Nov
EPS$-11.75
Beat 22.2%
Q2 202111 Aug
EPS$-15.35
Miss 20.8%
Q1 202111 May
EPS$-14.39
Miss 30.5%
Q4 202016 Mar
EPS$-18.94
Miss 2605.7%
Q3 202012 Nov
EPS$-20.86
Miss 7.4%
Q2 202011 Aug
EPS$-22.06
Miss 1596.9%
Q1 202014 May
EPS$-50.84
Miss 2480.7%
Q4 201919 Mar
EPS$-288.25
Miss 7106.3%
Q3 201912 Nov
EPS$-153.48
Miss 2225.4%
Q2 201912 Aug
EPS$-143.88
Miss 1612.9%
Q1 20199 May
EPS$-211.03
Miss 2193.8%
Q4 201825 Mar
EPS$-182.25
Miss 2236.5%
Q3 20188 Nov
EPS$-249.40
Miss 3017.5%
Q2 20189 Aug
EPS$-230.22
Miss 2031.7%
Q1 201810 May
EPS$-230.22
Q4 20178 Mar
EPS$-949.64
Q3 20179 Nov
EPS$-565.95
Q2 201710 Aug
EPS$-920.86
Q1 201711 May
EPS$-671.46
Q4 201622 Mar
EPS$-575.54
Q3 20169 Nov
EPS$1400.41
Q2 20168 Aug
EPS$-1119.03
Q1 201616 May
EPS$-96.00
Miss 4.3%
Q4 201529 Mar
EPS$-2101.95
Q3 201510 Nov
EPS$-88.00
Beat 15.4%
Q2 201512 Aug
EPS$-2547.90
Q1 201513 May
EPS$-96.00
Beat 0.0%
Q4 201419 Mar
EPS$-120.00
Beat 41.2%
Q3 20145 Nov
EPS$-288.00
Beat 25.0%
Q2 20146 Aug
EPS$-504.00
Beat 2.3%
Q1 201414 May
EPS$-552.00
Miss 9.5%
Q4 201327 Mar
EPS$-600.00
Miss 21.0%
Q3 20135 Nov
EPS$-504.00
Beat 11.3%
Q2 201331 Jul
EPS$-552.00
Miss 16.9%
Q1 20138 May
EPS$-480.00
Beat 7.0%
Q4 201226 Mar
EPS$-672.00
Miss 7.7%
Q3 20121 Nov
EPS$-552.00
Beat 5.0%
Q2 201226 Jul
EPS$-552.00
Beat 12.2%
Q1 201226 Apr
EPS$2088.00
Beat 3.6%
Q4 20116 Mar
EPS$-672.00
Beat 6.0%
Q3 20111 Nov
EPS$-672.00
Beat 5.9%
Q2 201127 Jul
EPS$-792.00
Miss 1.5%
Q1 201127 Apr
EPS$-864.00
Beat 1.1%
Q4 20109 Mar
EPS$-840.00
Beat 6.4%
Q3 20108 Nov
EPS$-888.00
Miss 5.7%
Q2 201028 Jul
EPS$-864.00
Miss 8.5%
Q1 201028 Apr
EPS$-888.00
Miss 15.0%
Q4 200910 Mar
EPS$-936.00
Beat 11.9%
Q3 200929 Oct
EPS$-984.00
Beat 9.7%
Q2 200929 Jul
EPS$-1008.00
Beat 4.1%
Q1 20096 May
EPS$-960.00
Beat 7.4%
Q4 200811 Mar
EPS$-960.00
Miss 0.4%
Q3 20085 Nov
EPS$-1008.00
Miss 5.4%
Q2 200811 Aug
EPS$-936.00
Miss 3.5%
Q1 20087 May
EPS$-888.00
Miss 15.6%
Q4 200711 Mar
EPS$-792.00
Beat 15.4%
Q3 20075 Nov
EPS$-888.00
Miss 2.8%
Q2 20077 Aug
EPS$-840.00
Miss 31.6%
Q1 200710 May
EPS$-528.00
Beat 20.7%
Q4 200629 Mar
EPS$-20358.19
Q4 20067 Mar
EPS$-1416.00
Miss 124.8%
Q1 200630 Jun
EPS$-34645.96
Q4 200531 Mar
EPS$-5873.02
Q3 200531 Dec
EPS$-34084.10
Q2 200530 Sept
EPS$-34106.58
Q1 200530 Jun
EPS$-34751.25
Q4 200431 Mar
EPS$-25385.49
Q3 200431 Dec
EPS$-20223.72
Q2 200430 Sept
EPS$-19973.23
Q1 200430 Jun
EPS$-19973.23
Q4 200331 Mar
EPS$-19973.23

No dividend data available for this stock.

Stock Splits

Split History

3 May 2024Reverse Split
Ratio1:24
16 Jan 2020Reverse Split
Ratio1:40
30 May 2017Reverse Split
Ratio1:10
27 May 2015Reverse Split
Ratio1:6

Similar Stocks

Based on congressional trading patterns

Smart Recommendations
No similar stocks found
No congressional trading patterns available for recommendations

Frequently Asked Questions about YTEN

Which members of Congress have traded YTEN?
1 member of Congress has disclosed 4 trade in Yield10 Bioscience, Inc. (YTEN) under the STOCK Act: Roger Marshall.
When was YTEN most recently disclosed by Congress?
The most recent YTEN disclosure was a sale by Roger Marshall on 14 March 2018.
What is the total disclosed congressional trading volume for YTEN?
Members of Congress have disclosed approximately $32K in YTEN sales (midpoint estimate derived from the bracketed amount ranges used in STOCK Act filings).
How can I track new congressional trades in YTEN?
This YTEN page updates as soon as new STOCK Act disclosures are filed for Yield10 Bioscience, Inc.. Every trade, politician, transaction date and amount range is surfaced above, typically within hours of the official filing appearing on the House or Senate disclosure portals.
Pelosi Tracker
PoliticiansBillsArticlesPortfoliosPricingAboutLegalTerms of ServicePrivacy Policy
Français
© 2026 - All rights reserved. Powered by Vantara Labs
Pelosi Tracker is an independent, third-party platform. It is not affiliated with, endorsed by, or in any way associated with Nancy Pelosi, her office or her representatives, or with any other member of Congress. Any use of her name is solely for the purpose of discussing publicly available information.The information provided by Pelosi Tracker is for informational and educational purposes only and is not intended to serve as, nor should it be construed as, financial or investment advice. The data presented here is sourced from publicly available filings and records. While we strive for accuracy, timeliness, and completeness, we do not guarantee that all information is error-free or current.